우리나라 약물유해반응 감시체계

참고문헌 (9)

1. Lazarou J, "Incidence of adverse drug reactions in hospitalized Figure 2", 179(15), pp.1200~1205 (1998), National Statistical Office
2. Jha AK, "Identifying hospital admissions due to adverse drug events using a computer-based monitor", 10(2), pp.113~119 (2001)
3. Korea Food and Drug Administration (KFDA), "Provision of Safety Information Management Regulation of Drugs" (2004), Korea Food and Drug Administration (KFDA)
4. Park BJ, "Activation of drug adverse event spontaneous reporting.", 45(11), pp.1274~1279 (2002)
5. Park BJ, "Re-examination system for new drugsin Korea", 6(1), pp.3~15 (1998)
6. Waller PC, "Regulatory pharmacovigilance in the United Kingdom: Current principles and practice", 5(6), pp.363~375 (1996)
7. Waller PC, "A model for the future conduct of pharmacovigilance", 12(1), pp.17~29 (2003)
8. Hauben M, "Data mining in pharmacovigilance: The need for a balanced perspective", 28(10), pp.835~842 (2005)
9. Food and Drug Administration (FDA), "FDA Moderization Act of 1997. Public Law 105-115", pp.105~115 (2007), Food and Drug Administration (FDA)

관련 논문AI추천